ClinConnect ClinConnect Logo
Search / Trial NCT07040488

Study of Infrared Thermography in Diabetic Foot in Guadeloupe

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA GUADELOUPE · Jun 18, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Infrared Thermography Diabetic Foot Infection

ClinConnect Summary

This clinical trial is studying how the temperature of the feet differs between people with and without diabetes in Guadeloupe, especially focusing on those with diabetic foot infections or wounds. Using a special camera that detects heat (called infrared thermography), researchers want to compare the temperature in four specific areas on the bottom of the foot. This might help doctors better understand and monitor foot problems in people with diabetes.

Adults aged 65 to 74 of Afro-Caribbean origin who live in Guadeloupe may be eligible to join. This includes people without any health problems as well as those with type 1 or type 2 diabetes, both with and without foot ulcers (open sores). To participate, individuals must be covered by a social security plan and agree to take part in the study. People with certain conditions, like recent fractures, past leg surgeries, amputations, neurological diseases, pregnancy, or foot infections other than ulcers, cannot join. Participants will have their foot temperatures measured using the infrared camera, which is a painless and non-invasive process. This study is currently recruiting volunteers, and the results could lead to better ways to detect and care for diabetic foot issues in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria for Control Group
  • Adult patients
  • Patients of Afro-Caribbean origin
  • Volunteer patients free from pathology
  • Person affiliated to or beneficiary of a social security scheme.
  • Person who has agreed to sign a consent to participate in the study
  • Inclusion Criteria for diabetic patients:
  • Adult patients
  • Patients of Afro-Caribbean origin
  • Type 1 or type 2 diabetic patients with and without diabetic foot ulceration
  • Person affiliated to or beneficiary of a social security system.
  • Person who has agreed to sign a consent to participate in the study
  • Exclusion Criteria :
  • - Minors
  • patient with an active fracture or a history of fracture
  • a history of legs surgery
  • History of amputation
  • Bilateral diabetic ulceration
  • neurological disease (Parkinson, stroke, etc.)
  • pregnancy
  • Foot mycosis
  • refusal of consent

About Centre Hospitalier Universitaire De La Guadeloupe

The Centre Hospitalier Universitaire de la Guadeloupe (CHUG) is a prominent academic medical center dedicated to advancing healthcare through innovative research and clinical trials. Located in the French overseas department of Guadeloupe, CHUG combines cutting-edge medical practices with a commitment to improving patient outcomes across diverse populations. As a leading institution in the Caribbean region, CHUG collaborates with multidisciplinary teams to conduct rigorous clinical studies aimed at enhancing treatment protocols and contributing to medical knowledge. The center emphasizes ethical standards and patient safety, fostering an environment that supports both scientific inquiry and community health advancement.

Locations

Pointe à Pitre, , Guadeloupe

Patients applied

0 patients applied

Trial Officials

Vanéva CHINGAN-MARTINO, MD

Principal Investigator

CHU de la Guadeloupe

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported